IRISanRaf

STOCCHI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.586
AS - Asia 5.833
EU - Europa 1.406
SA - Sud America 429
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 80
OC - Oceania 25
Totale 16.469
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.706
TR - Turchia 2.072
SG - Singapore 1.744
CN - Cina 1.236
CA - Canada 808
IT - Italia 651
BR - Brasile 307
VN - Vietnam 265
DE - Germania 158
HK - Hong Kong 115
EU - Europa 110
GB - Regno Unito 90
IE - Irlanda 78
BE - Belgio 76
IN - India 66
UA - Ucraina 57
FR - Francia 54
BD - Bangladesh 50
PK - Pakistan 47
RU - Federazione Russa 41
IQ - Iraq 38
MX - Messico 38
JP - Giappone 37
NL - Olanda 34
IL - Israele 32
FI - Finlandia 28
AR - Argentina 26
CO - Colombia 24
PL - Polonia 24
EC - Ecuador 20
ES - Italia 20
SE - Svezia 20
VE - Venezuela 20
ZA - Sudafrica 20
KR - Corea 18
PH - Filippine 16
AU - Australia 15
ID - Indonesia 14
GR - Grecia 13
MA - Marocco 13
TN - Tunisia 12
CL - Cile 11
LT - Lituania 11
SA - Arabia Saudita 11
EG - Egitto 10
UZ - Uzbekistan 10
DK - Danimarca 9
KE - Kenya 9
MY - Malesia 9
JO - Giordania 8
RO - Romania 8
NZ - Nuova Zelanda 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
JM - Giamaica 6
NI - Nicaragua 6
SI - Slovenia 6
UY - Uruguay 6
CR - Costa Rica 5
HN - Honduras 5
KZ - Kazakistan 5
PE - Perù 5
PS - Palestinian Territory 5
TW - Taiwan 5
BG - Bulgaria 4
BO - Bolivia 4
PY - Paraguay 4
RS - Serbia 4
TT - Trinidad e Tobago 4
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
NG - Nigeria 3
NP - Nepal 3
AT - Austria 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
OM - Oman 2
SN - Senegal 2
SV - El Salvador 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
BW - Botswana 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
GA - Gabon 1
GF - Guiana Francese 1
GY - Guiana 1
KI - Kiribati 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 16.460
Salva come PNG Salva come JPEG
Città #
Kocaeli 1.743
San Mateo 1.283
San Jose 1.077
Ashburn 806
Toronto 755
Dallas 685
Singapore 464
Rome 404
Chandler 392
Houston 383
Santa Clara 380
Wilmington 373
Beijing 304
Lawrence 249
Princeton 249
Fairfield 151
Los Angeles 117
Hong Kong 108
Woodbridge 88
Ho Chi Minh City 86
Seattle 80
Ghent 76
Hanoi 72
Shanghai 70
Guangzhou 61
São Paulo 39
Islamabad 35
Shenzhen 34
Cambridge 33
Munich 32
Dublin 31
New York 30
Council Bluffs 29
Brooklyn 28
Milan 28
Netanya 25
Frankfurt am Main 22
Tokyo 22
Da Nang 21
Boston 20
Chicago 20
Warsaw 19
Wuhan 19
Chennai 18
Helsinki 18
Jiaxing 18
Rui'an 18
Montreal 17
Assago 16
Berlin 16
Boardman 16
London 16
Mexico City 16
San Francisco 16
Amsterdam 15
Baghdad 15
Stockholm 15
Rio de Janeiro 14
Belo Horizonte 12
Manchester 12
The Dalles 12
Dhaka 11
Orem 11
Washington 11
Xi'an 11
Quanzhou 10
Denver 9
Johannesburg 9
Phoenix 9
Pune 9
Redwood City 9
Wuxi 9
Xuzhou 9
Ankara 8
Istanbul 8
Nairobi 8
Quito 8
Santiago 8
West Jordan 8
Andover 7
Bogotá 7
Guayaquil 7
Haiphong 7
Kyiv 7
Medellín 7
Nanjing 7
Poplar 7
Redmond 7
Solagna 7
St Petersburg 7
Sydney 7
Tashkent 7
Amman 6
Ar Riyāḑ 6
Atlanta 6
Florence 6
Hải Dương 6
Jeddah 6
Lahore 6
Managua 6
Totale 11.527
Salva come PNG Salva come JPEG
Nome #
Conventional Treatment-related Motor Complications: Their Prevention and Treatment 135
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 132
Morbo di Parkinson: strategie terapeutiche e qualità della vita del malato 110
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease 95
A pharmacological study of dopaminergic receptors in planaria 93
L’alimentazione del paziente parkinsoniano 82
Apomorphine and lisuride infusion. A comparative chronic study 81
Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study 80
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 78
Analyzing gait variability and dual-task interference in patients with Parkinson's disease and freezing by means of the word-color Stroop test 78
Modification of respiratory function parameters in patients with severe Parkinson's disease 76
A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm 76
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score Epub 2016 75
Gastrointestinal dysfunction in Parkinson's disease 74
A novel summary kinematic index for postural characterization in subjects with Parkinson's disease 73
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor 73
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease 73
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 73
The coefficient of friction in Parkinson's disease gait 73
Neuroprotection in Parkinson's disease: clinical trials 72
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need 72
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease 72
Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson’s disease: a systematic review and meta-analysis 71
A pharmacological study of cocaine activity in planaria 70
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 70
Side-effects of subcutaneous apomorphine in Parkinson's disease 69
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia 68
Case Study 10 67
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease 67
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm 67
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives 66
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism 66
Jejunal delivery of levodopa methyl ester 65
White matter disease (Binswanger's encephalopathy) in chronic cerebrovascular disorders 65
Adherence to antiparkinson medication in a multicenter European study 65
One year treatment with lisuride delivery pump in Parkinson's disease 65
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 65
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients 64
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics 64
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 64
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment 64
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 64
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 64
Transient left bundle branch block following intravenous lisuride bolus 63
Combination of two different dopamine agonists in the management of Parkinson's disease 63
Obstacles to the development of a neuroprotective therapy for Parkinson's disease 63
Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients 63
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes 63
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease 63
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease 63
Clinical Experiences With Levodopa Methylester (Melevodopa) in Patients With Parkinson Disease Experiencing Motor Fluctuations: An Open-Label Observational Study 63
Transient atrial fibrillation after subcutaneous apomorphine bolus 63
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease 62
Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group 62
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 62
Management of gastrointestinal alterations in Parkinson's disease 61
Validation of the freezing of gait questionnaire in patients with Parkinson's disease 61
Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report 61
Case-control study of multiple system atrophy 61
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 60
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease 60
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease 60
Motor fluctuations in levodopa treatment: clinical pharmacology 60
Use of Apomorphine in Parkinson’s Disease 60
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data 60
Parkinson's Disease: Non-motor and non-dopaminergic Features 59
Instrumental diagnosis of multiple system atrophy 59
Antagonist effect of terguride in Parkinson's disease 59
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease 59
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease 59
Clinica Neurologica 59
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results 59
Correlation between systolic blood pressure variability and global longitudinal strain in patients with Parkinson's disease and dysautonomia 58
Constipation in Parkinson's Disease 58
Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA 58
Managing the critical problems of advanced Parkinson's disease 58
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease 58
The spectrum of "off" in Parkinson's disease: What have we learned over 40 years? 58
Novel parkin mutations detected in patients with early-onset Parkinson's disease 58
GIGYF2 mutations are not frequent cause of familiar Parkinson’s disease 58
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease 58
Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations 57
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease 57
trategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias 57
Dual dopamine agonist treatment in Parkinson's disease 57
The Parkinsonian Gait Spatiotemporal Parameters Quantified by a Single Inertial Sensor before and after Automated Mechanical Peripheral Stimulation Treatment 57
Alterations of thermoregulation in Parkinson's disease 57
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease 56
Utility of tolcapone in fluctuating Parkinson's disease 56
Levodopa: A new look at an old friend 56
An appraisal of the problem of dementia in Parkinson's disease 56
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation 56
Comparison between L-dopa and lisuride intravenous infusions: a clinical study 56
Determination of apomorphine in human plasma by alumina extraction and high-performance liquid chromatography with electrochemical detection 56
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease 56
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease 56
Why delaying levodopa is a good treatment strategy in early Parkinson's disease 56
Effects of terguride in patients with Huntington's disease 55
Non motor symptoms in progressive supranuclear palsy: prevalence and severity 55
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 55
Totale 6.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.968
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.960 0 0 0 0 0 0 0 0 0 47 1.746 167
2021/20222.486 11 761 758 9 6 1 209 281 18 351 6 75
2022/20231.298 561 35 12 118 83 31 2 86 93 113 160 4
2023/20241.031 4 19 81 243 50 45 15 60 13 87 26 388
2024/20252.630 127 591 159 126 95 387 118 185 389 24 90 339
2025/20265.983 499 553 387 263 563 880 1.120 437 456 825 0 0
Totale 16.877